« Back to the previous page

Also available in: Deutsch Nederlands

Biopharma investment fund for sale

Biopharma investment fund for sale

  • Investment amount: >20m EUR
  • Location: Worldwide
  • Reason for sale: The owners of this pharma investment fund decided to raise capital or to sell its biotech fund
  • #CFIE PHS014

Overview of this biopharma investment fund for sale

The owners of a licensing and development company with a form of a hybrid investment fund are looking or a buyer or for an investor. The fund is managed by an experienced team with long experience in pharma. Contact us to know more about this fund looking for investment.

Profile of this biopharma investment fund for sale

This company looking for an investor is a company, specialized in in-licensing early-stage biopharmaceutical assets, progressing them to their next value-creation point and out-license to industry partners. The company has a practical form of an investment fund, although officially it is a limited company.

The fund capital reaches 100M EUR, with participation from investors from 3M EUR. The fund is successful, its current stage at preclinical development complete. The fund has 20+ investors currently. The company Invests in early-stage assets, not companies. The main criteria for investing are

  • Control of clinical development
  • Reduced development overhead costs
  • Avoid high late-stage development costs

The company actively manages its assets, by a project management team. The fund promises that the investor's equity will be fully returned in year five of the project, with the Internal Rate of Return (IRR) of the cash flows reaching more than 50%.

If interested, we can send a presentation of the fund, in which more detailed information is included upon signing an NDA with CFIE.

Buy this biopharma
investment fund

Contact us to get details about this biopharma investment fund for sale

Activities of this biopharma investment fund for sale

The investment criteria of the fund are:

  • Quality of science
  • Licensing feasibility 
  • Patent Assessment
  • Preclinical development completed
  • Commercialization/Regulatory path
  • Fit with the existing portfolio 
  • Risk/Return to value inflexion 
  • Business case

The identified opportunities, in which the fund managers are considering investment, include

  • FSHD Muscular Dystrophy
  • Alzheimer disease
  • Depressive disorder 
  • Etc.

At some of the opportunities, the fund managers are already conducting a Due Diligence.

The company holds many partnerships with clinical organizations; currently, it has an Ongoing Clinical Trial Service Agreement with a CRO company in order to downstream clinical development at a reduced cost.

This fund can be a good opportunity to a major pharma player, who wants to get access to CRO organizations and good opportunities. More investors will be invited to the process to invest, therefore the investor can invest also a lower amount than 20M.

Highlights of this biopharma investment fund for sale

  • The company for sale is a limited company working as a fund, currently in funding phase
  • The fund is identifying opportunities in the pharma sector and investing according to its criteria
  • The fund has a unique investment model with large ROI without a 20-year commitment and easy exit

Information of this biopharma investment fund for sale

Please feel free to ask for more information about this biopharma investment fund for sale, looking for an investor. If this profile does not interest you, ask for our other pharmaceutical companies open for a sale or open to a strategic investor. We know the pharmaceutical industry. If you are looking for other pharmaceutical businesses for sale, please visit the section pharmaceutical companies for sale. If you are looking to sell your pharmaceutical business or you know about the pharmaceutical company for sale, please visit the section pharmaceutical companies wanted.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.